Related Experiment Video
Updated: May 30, 2025

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
Deciphering the Topology of Sitagliptin Using an Integrated Approach
Renny Mathew1, Brijith Thomas1
1Science Division, New York University Abu Dhabi, P.O. Box 129188, Abu Dhabi, United Arab Emirates.
This study precisely determined the structure of sitagliptin, a DPP-4 inhibitor for type 2 diabetes, using advanced NMR and electron diffraction. This ensures drug effectiveness and quality control in pharmaceutical manufacturing.
Area of Science:
- Pharmaceutical Chemistry
- Solid-State Chemistry
- Computational Chemistry
Background:
- Sitagliptin is a crucial dipeptidyl peptidase-4 (DPP-4) inhibitor for type 2 diabetes management.
- Accurate structural determination is essential for sitagliptin's efficacy, safety, and quality control in manufacturing.
Purpose of the Study:
- To elucidate the intricate structure of sitagliptin.
- To integrate advanced spectroscopic and computational techniques for comprehensive structural analysis.
- To establish a precedent for structural characterization of complex pharmaceutical compounds.
Main Methods:
- Solid-state nuclear magnetic resonance (NMR) spectroscopy with dynamic nuclear polarization (DNP-NMR).
- Three-dimensional (3D) electron diffraction (ED) NMR crystallography.
- Density functional theory (DFT) calculations.
Main Results:
- Detailed atomic-level structural information was obtained using DNP-enhanced solid-state NMR.
- 3D ED NMR crystallography provided complementary structural insights.
- DFT calculations validated experimental findings and offered theoretical electronic structure data.
Conclusions:
- The integrated approach successfully characterized sitagliptin's structure, enhancing precision in drug development.
- This study sets a benchmark for analyzing complex pharmaceutical molecules.
- Findings support improved quality control and manufacturing standards for diabetes treatments.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Related Concept Videos
Dipeptidyl Peptidase 4 Inhibitors
Methods for Studying Drug Absorption: In situ
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs
On the other hand, integral calculus focuses on...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...